|
Press Releases |
|
 |
|
Tuesday, May 28, 2024 |
|
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project |
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders. The data resulting from this project have been acquired by Boehringer Ingelheim, where this research will be continued, potentially paving the way for novel therapies. more info >> |
|
Thursday, May 16, 2024 |
|
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim |
XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. more info >> |
|
Tuesday, April 30, 2024 |
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg |
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to overcome the immunosuppressive microenvironment of solid tumors. more info >> |
|
Tuesday, February 6, 2024 |
|
New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine |
more info >> |
|
Friday, December 22, 2023 |
|
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research |
more info >> |
|
Tuesday, November 7, 2023 |
|
BioMed X Launches a New Call for Application in Autoimmune Disease Research |
more info >> |
|
Wednesday, November 1, 2023 |
|
BioMed X and AbbVie Start New Research Project in the USA |
more info >> |
|
Thursday, June 29, 2023 |
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
Thursday, April 27, 2023 |
|
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus |
BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. more info >> |
|
Tuesday, April 4, 2023 |
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Strengthening Hong Kong-Zhejiang Ties: The Hong Kong Investment Promotion - Zhejiang Ningbo Forum
Apr 26, 2025 21:40 HKT/SGT
|
|
|
Strengthening Hong Kong-Zhejiang Ties
Apr 25, 2025 21:05 HKT/SGT
|
|
|
Graphene Manufacturing Group Provides Quarterly ATM Sales Update
Apr 25, 2025 20:29 HKT/SGT
|
|
|
NEC achieves Japan's longest terrestrial wireless optical communication over 10 km
Apr 25, 2025 17:50 JST
|
|
|
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
Apr 25, 2025 15:49 HKT/SGT
|
|
|
Edvantage Group Announces FY2025 Interim Results
Apr 25, 2025 14:40 HKT/SGT
|
|
|
Olympus Appoints New CEO
Apr 25, 2025 15:30 JST
|
|
|
TIME Interconnect Technology Limited Announces Final Results For The Year Ended 31 December 2024
Apr 25, 2025 13:17 HKT/SGT
|
|
|
DENSO Announces Year-End Financial Results
Apr 25, 2025 12:17 JST
|
|
|
Mooreast Holdings Announces Business Update
Apr 25, 2025 10:00 HKT/SGT
|
|
|
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
Apr 24, 2025 18:43 HKT/SGT
|
|
|
DENSO and DELPHY Sign Memorandum of Understanding to Develop Data-Driven Smart Horticulture
Apr 24, 2025 18:43 JST
|
|
|
MyJCB App Wins "iF DESIGN AWARD 2025"
Apr 24, 2025 17:00 JST
|
|
|
Fujitsu launches new company 1FINITY to strengthen network products business
Apr 24, 2025 16:24 JST
|
|
|
MHIEC Completes Renovation of Core Facilities for Arita Municipal Recycle Plaza in Saga Prefecture
Apr 24, 2025 15:01 JST
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|